| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AMSURG CORP | 1,980 | 90,000 | 0.01% | ||
| 2 | BARD C R INC | 676 | 97,000 | 0.01% | ||
| 3 | WELLCARE HEALTH PLANS INC COM | 1,302 | 97,000 | 0.01% | ||
| 4 | PHARMERICA CORP | 3,441 | 98,000 | 0.01% | ||
| 5 | MCKESSON CORP | 530 | 99,000 | 0.01% | ||
| 6 | PDL BIOPHARMA INCORPORATED | 10,183 | 99,000 | 0.01% | ||
| 7 | MERGE HEALTHCARE INC | 43,478 | 99,000 | 0.01% | ||
| 8 | SYMMETRY MEDICAL I | 11,148 | 99,000 | 0.01% | ||
| 9 | CHARLES RIV LABS INTL INC | 1,860 | 100,000 | 0.01% | ||
| 10 | QUINTILES IMS HOLDINGS INC | 1,875 | 100,000 | 0.01% | ||
| 11 | BIOSPECIFICS TECHNOLOGIES CORP COM | 3,700 | 100,000 | 0.01% | ||
| 12 | Medassets Inc | 4,429 | 101,000 | 0.01% | ||
| 13 | MAGELLAN HEALTH INC COM NEW | 1,642 | 102,000 | 0.01% | ||
| 14 | HUMANA | 803 | 103,000 | 0.01% | ||
| 15 | ALMOST FAMILY INC COM | 4,708 | 104,000 | 0.01% | ||
| 16 | TRIPLE S MGMT CORP CL B | 5,880 | 105,000 | 0.01% | ||
| 17 | GENTIVA HEALTH SER | 7,052 | 106,000 | 0.01% | ||
| 18 | MOLINA HEALTHCARE INC | 2,380 | 106,000 | 0.01% | ||
| 19 | CHINA BIOLOGIC PRODS INC | 2,400 | 107,000 | 0.01% | ||
| 20 | ENSIGN GROUP INC COM | 3,509 | 109,000 | 0.01% | ||
| 21 | Exactech Inc | 4,464 | 113,000 | 0.01% | ||
| 22 | ICON PLC | 2,440 | 115,000 | 0.01% | ||
| 23 | SUNSHINE HEART INC | 25,000 | 140,000 | 0.01% | ||
| 24 | RADNET INC COM | 22,975 | 152,000 | 0.01% | ||
| 25 | ARENA PHARMACEUTICALS INC | 30,000 | 176,000 | 0.02% | Put | |
| 26 | UNIVERSAL HLTH SVCS INC | 2,236 | 214,000 | 0.02% | ||
| 27 | HEALTH NET INC | 6,025 | 250,000 | 0.02% | ||
| 28 | BIOLINERX LTD | 165,698 | 345,000 | 0.03% | ||
| 29 | MEDGENICS INC | 55,073 | 428,000 | 0.04% | ||
| 30 | CLOVIS ONCOLOGY INC | 10,917 | 452,000 | 0.04% | ||
| 31 | STEMCELLS INC COM NEW | 271,600 | 551,000 | 0.05% | ||
| 32 | TRANSGENOMIC INC | 183,957 | 687,000 | 0.07% | ||
| 33 | BIOTA PHARMACEUTIALS INC COM | 253,400 | 722,000 | 0.07% | ||
| 34 | Galmed Pharmaceuticals Ltd | 75,000 | 731,000 | 0.07% | ||
| 35 | ACHAOGEN INC COM | 60,000 | 838,000 | 0.08% | ||
| 36 | ONCOTHYREON INC COM N/C EFF 6/ | 292,779 | 949,000 | 0.09% | ||
| 37 | ICAD INC | 150,000 | 962,000 | 0.09% | ||
| 38 | OXIGENE INC | 379,200 | 982,000 | 0.10% | ||
| 39 | ATHERSYS INC | 601,852 | 1,077,000 | 0.11% | ||
| 40 | INCYTE | 20,000 | 1,129,000 | 0.11% | ||
| 41 | SYNERON MEDICAL LTD ORD SHS | 115,000 | 1,187,000 | 0.12% | ||
| 42 | Aquinox Pharmaceuticals Inc | 130,000 | 1,218,000 | 0.12% | ||
| 43 | EPIZYME INC COM | 42,602 | 1,326,000 | 0.13% | ||
| 44 | NEWLINK GENETICS CORP | 50,000 | 1,328,000 | 0.13% | Call | |
| 45 | EXELIXIS INC | 400,000 | 1,356,000 | 0.13% | Call | |
| 46 | Orexigen Therapeutics, Inc. | 224,000 | 1,384,000 | 0.14% | ||
| 47 | ANTHERA PHARMACEUTICALS INC | 478,456 | 1,622,000 | 0.16% | ||
| 48 | CHAMPIONS ONCOLOGY | 1,625,744 | 1,625,000 | 0.16% | ||
| 49 | DURECT CORP | 907,064 | 1,651,000 | 0.16% | ||
| 50 | LIGAND PHARMACEUTICALS INC | 27,843 | 1,734,000 | 0.17% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001019056-14-001053, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
